149 related articles for article (PubMed ID: 38698387)
1. Efficacy of Episil® in patients with hematologic malignancies: a comparative study.
Fukutani T; Yoshioka Y; Imori S; Yanagihara H; Sumi K; Myoken Y; Fujita Y; Yanamoto S
BMC Oral Health; 2024 May; 24(1):522. PubMed ID: 38698387
[TBL] [Abstract][Full Text] [Related]
2. Effects of an oral mucosa protective formulation on chemotherapy- and/or radiotherapy-induced oral mucositis: a prospective study.
Ueno T; Yatsuoka W; Ishiki H; Miyano K; Uezono Y
BMC Cancer; 2022 Jan; 22(1):90. PubMed ID: 35062896
[TBL] [Abstract][Full Text] [Related]
3. A Bioadhesive Barrier-Forming Oral Liquid Gel Improved Oral Mucositis and Nutritional Status in Patients With Head and Neck Cancers Undergoing Radiotherapy: A Retrospective Single Center Study.
Wei J; Wu J; Wang H; Wang B; Zhao T; Meng L; Dong L; Jiang X
Front Oncol; 2021; 11():617392. PubMed ID: 33692954
[TBL] [Abstract][Full Text] [Related]
4. Clinical investigation of use of Episil® oral solution in oral mucositis during radiotherapy for head and neck cancer.
Ito K; Tokura S; Takazawa I; Yoshida N; Nakanishi T; Akiyama K; Onuma Y; Adachi T; Harada H; Nojima H; Miura M; Yoshimura R; Kabasawa Y
Heliyon; 2023 Jun; 9(6):e15869. PubMed ID: 37260888
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of Acute Radiation Dermatitis in Breast Cancer Patients by a Bioadhesive Barrier-Forming Gel (Episil): A Single-Center, Open, Parallel, Randomized, Phase I/II Controlled Trial.
Li Q; Feng S; Yu Z; Wang Y; Tian L; Geng H; Guo C; Ning F; Luo J; Liu C
Clin Pharmacol Ther; 2024 May; 115(5):1085-1091. PubMed ID: 38159264
[TBL] [Abstract][Full Text] [Related]
6. Assessment of indomethacin oral spray for the treatment of oropharyngeal mucositis-induced pain during anticancer therapy.
Momo K; Nagaoka H; Kizawa Y; Bukawa H; Chiba S; Kohda Y; Homma M
Support Care Cancer; 2017 Oct; 25(10):2997-3000. PubMed ID: 28711976
[TBL] [Abstract][Full Text] [Related]
7. Photobiomodulation in the management of oral mucositis for adult head and neck cancer patients receiving irradiation: the LiTEFORM RCT.
Nugent M; Bryant V; Butcher C; Fisher H; Gill S; Goranova R; Hiu S; Lindley L; O'Hara J; Oluboyede Y; Patterson J; Rapley T; Robinson T; Rousseau N; Ryan V; Shanmugasundaram R; Sharp L; Smith Whelan R; Stocken DD; Ternent L; Wilson J; Walker J
Health Technol Assess; 2022 Dec; 26(46):1-172. PubMed ID: 36484364
[TBL] [Abstract][Full Text] [Related]
8. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced mucositis: a randomized clinical trial of micronized sucralfate versus salt & soda mouthwashes.
Dodd MJ; Miaskowski C; Greenspan D; MacPhail L; Shih AS; Shiba G; Facione N; Paul SM
Cancer Invest; 2003; 21(1):21-33. PubMed ID: 12643006
[TBL] [Abstract][Full Text] [Related]
11. The post hoc analysis comparing the severity grades of chemoradiotherapy-induced oral mucositis scored between the central and local assessors in a multicenter, randomized controlled trial of rebamipide for head and neck cancer.
Ueno T; Zenda S; Konishi T; Yurikusa T; Shibasaki Y; Nagamoto H; Fujii M
Int J Clin Oncol; 2019 Mar; 24(3):241-247. PubMed ID: 30426268
[TBL] [Abstract][Full Text] [Related]
12. Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical Trial.
Sio TT; Le-Rademacher JG; Leenstra JL; Loprinzi CL; Rine G; Curtis A; Singh AK; Martenson JA; Novotny PJ; Tan AD; Qin R; Ko SJ; Reiter PL; Miller RC
JAMA; 2019 Apr; 321(15):1481-1490. PubMed ID: 30990550
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of Oro-T oral rinse in oral mucositis during cancer radiotherapy and/or chemotherapy: Cumulative analysis of two studies.
Koushik K; Janaki MG; Kumawat R; Paramesh R; Palaniyamma D
J Cancer Res Ther; 2021; 17(6):1503-1509. PubMed ID: 34916385
[TBL] [Abstract][Full Text] [Related]
14. Low-energy He/Ne laser in the prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck cancer.
Bensadoun RJ; Franquin JC; Ciais G; Darcourt V; Schubert MM; Viot M; Dejou J; Tardieu C; Benezery K; Nguyen TD; Laudoyer Y; Dassonville O; Poissonnet G; Vallicioni J; Thyss A; Hamdi M; Chauvel P; Demard F
Support Care Cancer; 1999 Jul; 7(4):244-52. PubMed ID: 10423050
[TBL] [Abstract][Full Text] [Related]
15. Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis.
Shaiova L; Lapin J; Manco LS; Shasha D; Hu K; Harrison L; Portenoy RK
Support Care Cancer; 2004 Apr; 12(4):268-73. PubMed ID: 14750002
[TBL] [Abstract][Full Text] [Related]
16. RADIATION-INDUCED MUCOSITIS IN PATIENTS WITH HEAD AND NECK CANCER: SHOULD THE SIGNS OR THE SYMPTOMS BE MEASURED?
Gussgard AM; Jokstad A; Hope AJ; Wood R; Tenenbaum H
J Can Dent Assoc; 2015; 81():f11. PubMed ID: 26214833
[TBL] [Abstract][Full Text] [Related]
17. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
18. A protocol for the evaluation and treatment of oral mucositis in patients with hematological malignancies.
Puyalt Casado M; Jiménez Martinez C; Chimenos Küstner E; López López J; Juliá A
Med Oral; 2003; 8(1):10-8. PubMed ID: 12556718
[TBL] [Abstract][Full Text] [Related]
19. Local analgesic effect of a bioadhesive barrier-forming oral liquid in cancer patients with oral mucositis caused by chemotherapy and/or radiotherapy: a randomized multicenter, single-use, positive-controlled, open-label study.
Cheng Y; Qin SK; Chen YP; Dong LH; Sun XD; Yu SY; Wu SK
Onco Targets Ther; 2018; 11():8555-8564. PubMed ID: 30584316
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies.
Hong JP; Lee SW; Song SY; Ahn SD; Shin SS; Choi EK; Kim JH
Eur J Cancer Care (Engl); 2009 Nov; 18(6):636-41. PubMed ID: 19456848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
